Status:

COMPLETED

Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects

Lead Sponsor:

Corin

Conditions:

Osteoarthritis

Avascular Necrosis

Eligibility:

All Genders

Brief Summary

primary endpoint of this Study is maintenance of "at least good clinical status" for a period of 10 years following initial implantation among Cormet procedures enrolled inthe pre-market IDE.

Detailed Description

Maintaining "at least good clinical status" will be determined based upon the composite clinical success (CCS) criterion which includes no revision, removal, or replacement of any device component and...

Eligibility Criteria

Inclusion

  • subjects enrolled in the Cormet IDE study at the 5 identified clinical sites
  • Individuals who agree to participate in the study by signing the informed patient consent form

Exclusion

  • none

Key Trial Info

Start Date :

May 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2017

Estimated Enrollment :

231 Patients enrolled

Trial Details

Trial ID

NCT00721994

Start Date

May 1 2008

End Date

August 1 2017

Last Update

November 21 2018

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Space Coast Orthopaedics Ctr.

Merritt Island, Florida, United States, 32953

2

Kennedy White Orthopedics

Sarasota, Florida, United States, 34233

3

Southern Illinois University School of Medicine

Springfield, Illinois, United States, 62702

4

Good Samaritan Hospital

Baltimore, Maryland, United States, 21239